Litcius/Paper detail

Bleeding in Patients With Gastrointestinal Cancer Compared With Nongastrointestinal Cancer Treated With Apixaban, Rivaroxaban, or Enoxaparin for Acute Venous Thromboembolism

Damon E. Houghton, Danielle T. Vlazny, Ana I. Casanegra, Nichole Brunton, David A. Froehling, Ryan A. Meverden, David O. Hodge, Lisa Peterson, Robert D. McBane, Waldemar E. Wysokiński

2021Mayo Clinic Proceedings45 citationsDOI

Topics & Concepts

MedicineApixabanRivaroxabanCancerInternal medicineColorectal cancerGastroenterologyColonoscopyWarfarinAtrial fibrillationVenous Thromboembolism Diagnosis and ManagementHeparin-Induced Thrombocytopenia and ThrombosisInflammatory Biomarkers in Disease Prognosis
Bleeding in Patients With Gastrointestinal Cancer Compared With Nongastrointestinal Cancer Treated With Apixaban, Rivaroxaban, or Enoxaparin for Acute Venous Thromboembolism | Litcius